Pfizer hires Citi analyst Andrew Baum to oversee portfolio strategy – Endpoints

Pfizer shutterstock social31

Pfiz­er has tapped Wall Street an­a­lyst An­drew Baum to be its new chief strat­e­gy and in­no­va­tion of­fi­cer, where he’ll head up man­age­ment of the com­pa­ny’s port­fo­lio and work on part­ner­ships.

Baum has been an in­vest­ment an­a­lyst for more than two decades, most re­cent­ly at Citi, where he led the bank’s health­care re­search. Pre­vi­ous­ly, he spent 14 years at Mor­gan Stan­ley and has al­so been a work­ing physi­cian.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

This article was originally published by a

Read it HERE


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *